Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factor
Thibault Maillet, Tiphaine Goletto, Guillaume Beltramo, et al.
Journal of Autoimmunity (2019) Vol. 106, pp. 102338-102338
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Clinical Profiles, Survival, and Lung Function Outcomes in ANCA-Associated Interstitial Lung Disease: An Observational Study
Cristina Valero, Claudia Valenzuela, Juan Pablo Baldivieso-Achá, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 1, pp. 229-229
Open Access | Times Cited: 2
Spectrum of Fibrotic Lung Diseases
Faiz Karim, Jan van Laar, Martin van Hagen
New England Journal of Medicine (2020) Vol. 383, Iss. 25, pp. 2485-2486
Closed Access | Times Cited: 104
Interstitial lung disease, antineutrophil cystoplasmic antibodies and microscopic polyangiitis
Ulrich Specks, Paige K. Marty
Lara D. Veeken (2025) Vol. 64, Iss. Supplement_1, pp. i42-i47
Closed Access | Times Cited: 1
Prevalence and clinical significance of anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis-associated interstitial lung disease
Zhe Huang, Tingting Wu, Rongdan Lu, et al.
BMC Pulmonary Medicine (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders
Masataka Kuwana, Albert Gil‐Vila, Albert Selva-O’Callaghan
Therapeutic Advances in Musculoskeletal Disease (2021) Vol. 13
Open Access | Times Cited: 45
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review
Suha Kadura, Ganesh Raghu
European Respiratory Review (2021) Vol. 30, Iss. 162, pp. 210123-210123
Open Access | Times Cited: 43
Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them?
Domenico Sambataro, Gianluca Sambataro, Francesca Pignataro, et al.
Diagnostics (2020) Vol. 10, Iss. 4, pp. 208-208
Open Access | Times Cited: 45
Natural history and screening of interstitial lung disease in systemic autoimmune rheumatic disorders
P. Panagopoulos, Andreas V. Goules, Anna‐Maria Hoffmann‐Vold, et al.
Therapeutic Advances in Musculoskeletal Disease (2021) Vol. 13
Open Access | Times Cited: 39
Granulomatosis with polyangiitis: clinical characteristics and updates in diagnosis
Malgorzata Potentas-Policewicz, Justyna Fijołek
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 6
Pathogenesis of Pulmonary Manifestations in ANCA-Associated Vasculitis and Goodpasture Syndrome
Evangelia Fouka, Fotios Drakopanagiotakis, Paschalis Steiropoulos
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5278-5278
Open Access | Times Cited: 5
Long-Term Prognostic Factors in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A 15-Year Multicenter Retrospective Study
Qian-Qian Liao, Ya-Fei Ren, Ke‐Wei Zhu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort
Karl Gisslander, Arthur White, Louis J. M. Aslett, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 11, pp. e762-e770
Closed Access | Times Cited: 4
Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis
Hironao Hozumi, Masato Kono, Hirotsugu Hasegawa, et al.
CHEST Journal (2021) Vol. 159, Iss. 6, pp. 2334-2345
Closed Access | Times Cited: 27
Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort study
Ayana Okazaki, Shogo Matsuda, Takuya Kotani, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Risk factors for poor prognosis in ANCA-associated vasculitis with interstitial lung disease: a systematic review and meta-analysis
Xing He, Weiwei Yuan, Yahui Yang, et al.
Clinical Rheumatology (2025)
Open Access
Interstitial Lung Disease in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Chest CT Patterns and Correlation with Survival
Marta Casal Moura, Yasmeen K. Tandon, Thomas E. Hartman, et al.
Seminars in Arthritis and Rheumatism (2025), pp. 152726-152726
Closed Access
Immune-mediated lung diseases: A narrative review
Jaleel Jerry G. Sweis, Nabil William G Sweis, Fatima Alnaimat, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 9
Presentation and progression of MPO-ANCA interstitial lung disease
Lorenzo Salvati, Boaz Palterer, Elena Lazzeri, et al.
Journal of Translational Autoimmunity (2024) Vol. 8, pp. 100235-100235
Open Access | Times Cited: 3
Pulmonary involvement of ANCA-associated vasculitis in adult Chinese patients
Peining Zhou, Zhiying Li, Li Gao, et al.
BMC Pulmonary Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review
Hideaki Yamakawa, Yuko Toyoda, Tomohisa Baba, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3835-3835
Open Access | Times Cited: 13
Long‐term survival, causes of death, and prognostic factors for mortality in patients with microscopic polyangiitis and those with anti‐neutrophil cytoplasmic antibody‐positive interstitial lung disease: A single‐center retrospective study
Yukiko Takakuwa, Yoshioki Yamasaki, Hiromi Matsushita, et al.
International Journal of Rheumatic Diseases (2022) Vol. 26, Iss. 3, pp. 446-453
Closed Access | Times Cited: 13
Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: an update on pathogenesis and treatment
David Turgeon, Meyer Balter, Christian Pagnoux
Current Opinion in Pulmonary Medicine (2023) Vol. 29, Iss. 5, pp. 436-442
Closed Access | Times Cited: 8
Comparison of Interstitial Lung Disease Between Antineutrophil Cytoplasmic Antibodies Positive and Negative Patients: A Retrospective Cohort Study
Hao Cheng Shen, Khai‐Tuan Andrew Bui, R. Richard, et al.
ACR Open Rheumatology (2024) Vol. 6, Iss. 8, pp. 463-469
Open Access | Times Cited: 2
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
Caterina Vacchi, Andreina Manfredi, Giulia Cassone, et al.
Drugs in Context (2021) Vol. 10, pp. 1-12
Open Access | Times Cited: 16
Impact of interstitial lung disease on mortality in ANCA-associated vasculitis: A systematic literature review and meta-analysis
Peining Zhou, Jing Ma, Guangfa Wang
Chronic Respiratory Disease (2021) Vol. 18
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top